Evalyn Mulder

Dr. Evalyn Mulder is a researcher in the Department of Surgery at Erasmus MC, a leading academic medical center in the Netherlands. Her work is centered in the field of surgical oncology with a strong emphasis on melanoma and immunotherapeutic interventions. She actively contributes to high-impact clinical research and collaborative multicenter studies.

Research Interests: Dr. Mulder's research spans melanoma biology, gene expression profiling, and the optimization of immunotherapies such as ipilimumab and nivolumab. Her work investigates adjuvant therapy strategies, treatment duration, and the clinical utility of biomarkers in guiding patient management. She is particularly interested in translational approaches that bridge laboratory findings with clinical outcomes.

Publication Trends: Her recent publications reveal a strong focus on clinical trials, immune checkpoint inhibitors, and the molecular and pathological characteristics of melanoma. The articles highlight her involvement in designing and evaluating protocols for treatment discontinuation, metastasis screening, and novel therapeutic applications in dermatological and oncological contexts.

Scientific Awards:

• No specific awards mentioned in the provided text.

Advising and Grants: While no formal students or grant funding details are listed, Dr. Mulder plays a significant role in major collaborative research projects and clinical trials, often co-leading studies with senior investigators. Her contributions suggest active participation in research mentorship and team-based academic inquiry.

Labs and Teams: Dr. Mulder is embedded in a multidisciplinary research network at Erasmus MC focused on melanoma and surgical oncology. She collaborates extensively with experts in medical oncology, pathology, radiology, and immunology, contributing to a robust research ecosystem aimed at improving cancer outcomes.